Turkey
Oculera, founded in 2020, is a promising player in the field of ocular health technologies with the mission to redefine eye diagnostics and treatments. With its inaugural product—a perimetry test conducted via a virtual reality headset—already receiving Class IIA CE certification, Oculera demonstrates readiness to disrupt the traditional eye health sectors.
Operating out of Turkey, Oculera spans several industries, including Digital Health, Health Tech, and SaaS, equipping it with a diversified platform for growth. The company secured its latest funding, a $3.00M Seed investment from ÜNLÜ & Co. in November 2025, which underscores strong investor confidence in its vision.
As a player in the Health and Wellness sector, Oculera is well positioned at the intersection of innovation and care, crafting technologies that offer effective diagnostic solutions globally. Investors should monitor its technological advancements and regulatory milestones as key indicators for scalability and market penetration.
